ROBERT LAFLEUR: Open Payments
NPI 1043260177 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 34 payments from 3 companies in 2025. Trend: 2023 $9,663 · 2024 $7,039 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $570 |
| Alkermes, Inc. | 8 | $203 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
Products named: REXULTI, ARISTADA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
